Global analysis of mRNA decay in Bacillus subtilis

枯草芽孢杆菌 mRNA 衰减的整体分析

基本信息

项目摘要

DESCRIPTION (provided by applicant): Our laboratory seeks to understand the process of messenger RNA decay in the model Gram-positive bacterium, Bacillus subtilis. While much is known about the mechanisms and regulation of transcription of DNA into mRNA and translation of mRNA into protein, relatively little is known about the intermediate step in gene expression - degradation of mRNA. Earlier work identified two major 3' exoribonucleases in B. subtilis, PNPase and RNase R, which can efficiently degrade mRNA decay intermediates subsequent to a decay-initiating endonuclease cleavage. More recently, two new classes of bacterial ribonucleases, the RNase J and RNase Y families, were discovered in B. subtilis. One of the B. subtilis RNase J enzymes, RNase J1, is a particular focus of interest as it specifies a 5'-to-3' exonuclease activity, an activity that is not present in more well-studied bacteria, such as E. col. The presence of a 5' exoribonuclease expands the scope of possible mechanisms by which mRNA can be degraded. New studies of RNase Y, an endonuclease, suggest that it plays a key role in determining the half-life of many mRNAs. This proposal applies the power of RNA-Seq (deep RNA sequencing) technology to explore mechanisms of mRNA decay at the transcriptome level. In particular, application of standard RNA-Seq to exoribonuclease mutant strains will be used to examine the role of 3' exonucleases, primarily PNPase and RNase R, in the turnover of mRNA decay intermediates. These studies will shed light on the question of ribonuclease redundancy, and whether specific ribonucleases act in the turnover of particular mRNAs. In addition, standard RNA-Seq will be used to study the role of RNase J1 5' exonuclease activity in the turnover of 3'-terminal fragments that contain the RNase-resistant transcription terminator structure. A modified RNA-Seq protocol called PARE (parallel analysis of RNA ends), which has been used by a number of laboratories to study eukaryotic mRNA processing, will be used to map 5'-monophosphate ends that arise in the course of mRNA decay. This protocol will be used to study the nature and distribution of cleavages by RNase Y, the major B. subtilis endonuclease, as well as by RNase III, a narrow-specificity endonuclease that is essential in B. subtilis. PARE will also be used to detect conversion of the native transcription product 5'-triphosphate end to a 5'- monophosphate end. This conversion may be a precursor step in the degradation of full-length mRNAs. RELEVANCE: Degradation of messenger RNA is an important step in regulating gene expression and is an essential function of bacteria. A thorough understanding of the mechanism of mRNA decay will enable design of antimicrobial agents that disrupt this process and thereby interfere with bacterial cell growth. PUBLIC HEALTH RELEVANCE: Messenger RNA (mRNA), the template molecule upon which proteins are synthesized, needs to be turned over rapidly to adapt to changing environments and to recycle the pool of ribonucleotides needed for new RNA synthesis. The mechanisms by which mRNA is degraded will be studied in detail in the model microorganism, Bacillus subtilis, using deep RNA sequencing technology that facilitates global views of RNA processes. Elucidating the mechanism of mRNA decay could lead to the design of antibiotics that inhibit this essential process and thereby prevent bacterial colonization of human tissues.
描述(由申请人提供):我们的实验室试图了解模型革兰氏阳性细菌枯草芽孢杆菌中信使RNA衰变的过程。虽然对DNA转录成mRNA和mRNA翻译成蛋白质的机制和调控了解很多,但对基因表达的中间步骤-mRNA降解-了解相对较少。早期的工作在B中鉴定了两种主要的3'核糖核酸外切酶。枯草芽孢杆菌、PNase和RNase R,其可以有效地降解衰变起始核酸内切酶切割后的mRNA衰变中间体。最近,在B中发现了两类新的细菌核糖核酸酶,RNase J和RNase Y家族。枯草杆菌。其中一个B。枯草杆菌RNA酶J酶,RNA酶J1,是一个特别感兴趣的焦点,因为它指定了5 ′至3 ′外切核酸酶活性,这种活性不存在于更充分研究的细菌,如大肠杆菌。5'核糖核酸外切酶的存在扩大了mRNA降解的可能机制的范围。RNase Y是一种核酸内切酶,新的研究表明,它在决定许多mRNA的半衰期方面起着关键作用。该提案应用RNA-Seq(深度RNA测序)技术的力量来探索转录组水平上mRNA衰变的机制。特别地,将标准RNA-Seq应用于核糖核酸外切酶突变株将用于检查3'核酸外切酶(主要是PNase和RNase R)在mRNA衰变中间体的周转中的作用。这些研究将阐明核糖核酸酶冗余的问题,以及特定的核糖核酸酶是否在特定mRNA的周转中起作用。此外,标准RNA-Seq将用于研究RNase J1 5'外切核酸酶活性在含有RNase抗性转录终止子结构的3'末端片段的周转中的作用。一种被称为帕雷(RNA末端平行分析)的改良RNA-Seq方案,已被许多实验室用于研究真核mRNA加工,将用于绘制mRNA衰变过程中出现的5 '-单磷酸末端。本方案将用于研究RNase Y(主要B)裂解的性质和分布。枯草杆菌核酸内切酶,以及RNase III,一种在B中必不可少的窄特异性核酸内切酶。枯草杆菌。帕雷还将用于检测天然转录产物5 '-三磷酸末端向5'-单磷酸末端的转化。这种转化可能是全长mRNA降解的前体步骤。相关性:信使RNA的降解是调节基因表达的重要步骤,也是细菌的基本功能。对mRNA衰变机制的透彻理解将使抗微生物剂的设计能够破坏这一过程,从而干扰细菌细胞生长。 公共卫生关系:信使RNA(mRNA)是合成蛋白质的模板分子,需要快速转换以适应不断变化的环境,并回收新RNA合成所需的核糖核苷酸库。mRNA降解的机制将在模型微生物枯草芽孢杆菌中详细研究,使用深度RNA测序技术,促进RNA过程的全局视图。阐明mRNA衰变的机制可能会导致抗生素的设计,抑制这一重要过程,从而防止细菌在人体组织中定植。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DAVID H BECHHOFER其他文献

DAVID H BECHHOFER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DAVID H BECHHOFER', 18)}}的其他基金

YloC, a new ribonuclease of Bacillus subtilis
YloC,枯草芽孢杆菌的新型核糖核酸酶
  • 批准号:
    10736779
  • 财政年份:
    2023
  • 资助金额:
    $ 33.42万
  • 项目类别:
Global analysis of mRNA decay in Bacillus subtilis
枯草芽孢杆菌 mRNA 衰减的整体分析
  • 批准号:
    8515472
  • 财政年份:
    2012
  • 资助金额:
    $ 33.42万
  • 项目类别:
Global analysis of mRNA decay in Bacillus subtilis
枯草芽孢杆菌 mRNA 衰减的整体分析
  • 批准号:
    8371861
  • 财政年份:
    2012
  • 资助金额:
    $ 33.42万
  • 项目类别:
Initiation of mRNA decay in Bacillus subtilis
枯草芽孢杆菌中 mRNA 降解的启动
  • 批准号:
    7921228
  • 财政年份:
    2009
  • 资助金额:
    $ 33.42万
  • 项目类别:
Initiation of mRNA decay in Bacillus subtilis
枯草芽孢杆菌中 mRNA 降解的启动
  • 批准号:
    6470300
  • 财政年份:
    1993
  • 资助金额:
    $ 33.42万
  • 项目类别:
Initiation of mRNA decay in Bacillus subtilis
枯草芽孢杆菌中 mRNA 降解的启动
  • 批准号:
    7092749
  • 财政年份:
    1993
  • 资助金额:
    $ 33.42万
  • 项目类别:
Initiation of mRNA decay in Bacillus subtilis
枯草芽孢杆菌中 mRNA 降解的启动
  • 批准号:
    7629564
  • 财政年份:
    1993
  • 资助金额:
    $ 33.42万
  • 项目类别:
INITIATION OF MRNA DECAY IN BACILLUS SUBTILIS
枯草芽孢杆菌中 mRNA 衰变的启动
  • 批准号:
    2186314
  • 财政年份:
    1993
  • 资助金额:
    $ 33.42万
  • 项目类别:
INITIATION OF MRNA DECAY IN BACILLUS SUBTILIS
枯草芽孢杆菌中 mRNA 衰变的启动
  • 批准号:
    2022688
  • 财政年份:
    1993
  • 资助金额:
    $ 33.42万
  • 项目类别:
Initiation of mRNA decay in Bacillus subtilis
枯草芽孢杆菌中 mRNA 降解的启动
  • 批准号:
    8073263
  • 财政年份:
    1993
  • 资助金额:
    $ 33.42万
  • 项目类别:

相似海外基金

Mechanistic insights into multifaceted roles of coronavirus exoribonuclease complex
冠状病毒外核糖核酸酶复合物多方面作用的机制见解
  • 批准号:
    10713523
  • 财政年份:
    2023
  • 资助金额:
    $ 33.42万
  • 项目类别:
Novel Function(s) of Arenavirus NP Exoribonuclease
Arenavirus NP 核糖核酸外切酶的新功能
  • 批准号:
    10525101
  • 财政年份:
    2022
  • 资助金额:
    $ 33.42万
  • 项目类别:
Novel Function(s) of Arenavirus NP Exoribonuclease
Arenavirus NP 核糖核酸外切酶的新功能
  • 批准号:
    10624457
  • 财政年份:
    2022
  • 资助金额:
    $ 33.42万
  • 项目类别:
Characterizing the XRN1 exoribonuclease as a therapeutic target in non-small cell lung cancer
将 XRN1 核糖核酸外切酶表征为非小细胞肺癌的治疗靶点
  • 批准号:
    10215766
  • 财政年份:
    2021
  • 资助金额:
    $ 33.42万
  • 项目类别:
Exploring the Coronavirus Exoribonuclease as an Antiviral Target
探索冠状病毒外核糖核酸酶作为抗病毒靶点
  • 批准号:
    10238324
  • 财政年份:
    2021
  • 资助金额:
    $ 33.42万
  • 项目类别:
Characterizing the XRN1 exoribonuclease as a therapeutic target in non-small cell lung cancer
将 XRN1 核糖核酸外切酶表征为非小细胞肺癌的治疗靶点
  • 批准号:
    10656174
  • 财政年份:
    2021
  • 资助金额:
    $ 33.42万
  • 项目类别:
Characterizing the XRN1 exoribonuclease as a therapeutic target in non-small cell lung cancer
将 XRN1 核糖核酸外切酶表征为非小细胞肺癌的治疗靶点
  • 批准号:
    10370384
  • 财政年份:
    2021
  • 资助金额:
    $ 33.42万
  • 项目类别:
Exploiting the SARS-CoV-2 nsp14 3'-5'-exoribonuclease as a target for antiviral chemotherapy
利用 SARS-CoV-2 nsp14 3-5-核糖核酸外切酶作为抗病毒化疗的靶点
  • 批准号:
    MR/V036904/1
  • 财政年份:
    2020
  • 资助金额:
    $ 33.42万
  • 项目类别:
    Research Grant
Dissecting the role of the coronavirus proofreading exoribonuclease in RNA recombination
剖析冠状病毒校对核糖核酸酶在 RNA 重组中的作用
  • 批准号:
    10268982
  • 财政年份:
    2020
  • 资助金额:
    $ 33.42万
  • 项目类别:
Flow responsive endothelial Pnpt1: an exoribonuclease that regulates mitochondrial function and vascular disease
流量响应内皮 Pnpt1:一种调节线粒体功能和血管疾病的核糖核酸外切酶
  • 批准号:
    9750410
  • 财政年份:
    2018
  • 资助金额:
    $ 33.42万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了